STAT+

Health Amanda Gokee — Boston Globe

STAT Plus: Learning to treat long COVID could help those struggling with chronic fatigue syndrome, too

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Pfizer and Novo disclose upbeat data on oral weight loss drugs; PBM trade group blasts House committee over hearing

Biotech Jonathan Wosen

STAT Plus: Achieve Life Sciences drug helps smokers quit in trial but would face stiff competition if approved

Biotech Allison DeAngelis

STAT Plus: Biotech launches with $300 million, joint venture to expedite RNA drug development

Pharmalot Ed Silverman

STAT Plus: Seagen criticized by shareholder advisory firm for ‘problematic’ executive compensation ahead of Pfizer acquisition

Pharma Damian Garde

STAT Plus: Novo says oral version of Ozempic leads to 15% weight loss

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Many employer health plans won’t pay for obesity drugs; FDA panel rejects Intercept NASH drug

Pharma Elaine Chen

STAT Plus: In early trial, drug appears to reduce harmful protein buildup in heart

Biotech Megan Molteni

STAT Plus: In its first tough test, CRISPR epigenome editing cuts cholesterol levels in monkeys

Pharmalot Ed Silverman

STAT Plus: 1 in 5 primary endpoints changed in late-stage trials of cancer drugs already underway, study finds

Biotech Damian Garde

STAT Plus: FDA advisers vote against approving Intercept’s NASH drug

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Biotech Andrew Joseph

STAT Plus: FDA approves first treatment for skin condition that causes persistent wounds, a redosable gene therapy

Health Elaine Chen

STAT Plus: Novo Nordisk pauses ads for weight loss drug Wegovy as it struggles to meet demand

Politics John Wilkerson

STAT Plus: FDA official offers insights into whether gene therapy makers could use common manufacturing process

Health Tech Mario Aguilar

STAT Plus: Pear Therapeutics sold for parts at $6 million auction

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: AstraZeneca plans to ‘love’ China’s Communist Party; U.S. Supreme Court rules against Amgen in patent case

Pharmalot Ed Silverman

STAT Plus: Supreme Court rules against Amgen in closely watched case over scope of patent claims

Politics Sarah Owermohle and Brittany Trang

STAT Plus: New Biden science agency ARPA-H launches first program, targeting bone regrowth

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Appellate judges appear skeptical of FDA decisions on abortion pill; FTC widens probe into PBMs

Biotech Damian Garde

STAT Plus: In Belgium, a native son returns to resurrect the drugmaker Galapagos — and ‘to get the trust back’

Pharmalot Ed Silverman

STAT Plus: FTC widens probe into pharmacy benefit managers to include group purchasing organizations

Politics Rachel Cohrs

STAT Plus: House panel takes first steps toward reining in hospitals with ‘site-neutral’ changes

Politics John Wilkerson

STAT Plus: Could an upcoming Supreme Court case make the FDA slower?

Business Alexa Gagosz — Boston Globe

STAT Plus: CVS Health to close clinical trial unit two years after launch

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FTC suit over Amgen spotlights ‘bundling’ deals with insurers; FDA staff says Pfizer RSV vaccine is effective

Biotech Matthew Herper

STAT Plus: PTC Therapeutics’s PKU drug succeeds in trial, but bigger hurdles for company are ahead

Biotech Jason Mast

STAT Plus: A new startup looks to turn the workhorse of gene therapy against cancer

Health Tech Mario Aguilar

STAT Plus: Biotech and pharma execs wrestle with the ‘nightmare’ of developing digital biomarkers